Germline TP53 pathogenic variants and breast cancer: A narrative review
Cancer Treatment Reviews · 2023-03 · 114 · 102522
DOI: 10.1016/j.ctrv.2023.102522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-03. Verfasst von Eva Blondeaux und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: evablondeaux@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Li-Fraumeni Syndrome, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: evablondeaux@gmail.com.
- Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Ma…
- Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
- Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
- Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
- Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
Förderung
- Gilead Sciences
Zitieren
APA
Blondeaux, E., Arecco, L., Punie, K., Graffeo, R., Toss, A., De Angelis, C., Trevisan, L., Buzzatti, G., Linn, S. C., Dubsky, P., Cruellas, M., Partridge, A. H., Balmaña, J., Paluch-Shimon, S., & Lambertini, M. (2023). Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treatment Reviews, 114, 102522. https://doi.org/10.1016/j.ctrv.2023.102522
Vancouver
Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C, et al. Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treatment Reviews. 2023;114:102522. doi:10.1016/j.ctrv.2023.102522
BibTeX
@article{Blondeaux2023,
author = {Blondeaux, Eva and Arecco, Luca and Punie, Kevin and Graffeo, Rossella and Toss, Angela and De Angelis, Carmine and Trevisan, Lucia and Buzzatti, Giulia and Linn, Sabine C and Dubsky, Peter and Cruellas, Mara and Partridge, Ann H and Balmaña, Judith and Paluch-Shimon, Shani and Lambertini, Matteo},
title = {Germline TP53 pathogenic variants and breast cancer: A narrative review},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {114},
pages = {102522},
doi = {10.1016/j.ctrv.2023.102522}
}
EUVIMED